slotkoers
Andere beurzen
|
||
- EUR | - |
Omzet 2024 * | 291 mld. 41,75 mld. 39,03 mld. | Omzet 2025 * | 352 mld. 50,41 mld. 47,13 mld. | Marktkapitalisatie | 4.466 mld. 640 mld. 598 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 105 mld. 15,01 mld. 14,03 mld. | Nettowinst (verlies) 2025 * | 128 mld. 18,3 mld. 17,11 mld. | EV/omzet 2024 * | 15,4 x |
Nettoschuld 2024 * | 22,09 mld. 3,16 mld. 2,96 mld. | Nettoliquiditeiten 2025 * | 6,04 mld. 865 mln. 808 mln. | EV/omzet 2025 * | 12,7 x |
K/w-verhouding 2024 * |
43,9
x | K/w-verhouding 2025 * |
36
x | Werknemers | - |
Dividendrendement 2024 * |
1,15% | Dividendrendement 2025 * |
1,41% | Vrij verhandelbaar | 70,17% |
Recentste transcriptie over Novo Nordisk A/S
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 58 | 01-01-91 | |
Director of Finance/CFO | 53 | 01-01-99 | |
Stephen Gough
CTO | Chief Tech/Sci/R&D Officer | - | 01-10-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sylvie Grégoire
BRD | Director/Board Member | 62 | 19-03-15 |
Helge Lund
CHM | Chairman | 61 | 23-03-17 |
Martin MacKay
BRD | Director/Board Member | 68 | 01-03-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+54,66% | 815 mld. | |
-6,14% | 354 mld. | |
+21,39% | 337 mld. | |
+11,01% | 302 mld. | |
+18,45% | 247 mld. | |
+2,09% | 229 mld. | |
+13,03% | 219 mld. | |
+8,87% | 171 mld. | |
-4,57% | 159 mld. |